Special Investigation For Renal Cell Carcinoma (RCC) Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan)

NCT00716625 · clinicaltrials.gov ↗

COMPLETED

Status

1674

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Renal Cell

Interventions

DRUG: sunitinib malate

Sponsor

Pfizer